The candidates merge two existing vaccines that have demonstrated favourable tolerability through randomised controlled studies.

Sanofi CEO Paul Hudson says, "AI is a huge opportunity, and we can't be deniers." ...

根据中国商务部的声明，中国商务部长王文涛星期一在北京会见赛诺菲董事长弗雷德里克·乌代阿 (Frederic Oudea) 时说，“中国开放的大门只会越开越大，一视同仁支持企业开展科技创新、参与市场竞争，将为医药企业带来更多发展机遇。” ...

The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination vaccine candidates ...

Chinese authorities rolled out the red carpet for French pharmaceutical and healthcare giant Sanofi, which plans to invest around 1 billion euros (US$1.05 billion) to build a new insulin plant in ...

12月2日，跨国药企赛诺菲宣布，将投资约10亿欧元在北京亦庄设立全新生产制造基地，这将是赛诺菲在华第四个生产供应基地，创造了该企业在华最大单笔投资纪录，有望大幅提升胰岛素本地端到端生产制造能力，服务本土糖尿病患者的胰岛素用药需求。当天，赛诺菲与北京经 ...

Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest ...

A drug developed by Sanofi raised platelet counts and reduced bleeding episodes in patients with a rare autoimmune disorder ...

The new base, which will be located in Yizhuang, Beijing, marks Sanofi’s second production site in the capital and its fourth ...

SHANGHAI, Dec 2 (Reuters) - Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production ...

Sanofi (SNY) says new data from three oral presentations demonstrated significant clinical benefit with Sarclisa-based quadruplets in newly ...